Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

European Medicines Group

This page shows the latest European Medicines Group news and features for those working in and with pharma, biotech and healthcare.

How to keep your name development on schedule after the recent EMA NRG announcement

How to keep your name development on schedule after the recent EMA NRG announcement

Three key action points. For those individuals and companies invited to attend the European Medicines Agency Name Review Group (EMA NRG) joint meetings, we are given the first chance to receive

Latest news

  • EMA's new pharmacovigilance committee holds first meeting EMA's new pharmacovigilance committee holds first meeting

    The first two-day meeting of the European Medicines Agency's (EMA) newest working group, the Pharmacovigilance Risk Assessment Committee (PRAC), began yesterday in Brussels as the Agency initiated plans to ... The EMA said: “[The] establishment of new

  • EMA geriatric expert group

    EMA geriatric expert group. The European Medicines Agency has established an expert group to provide advice on issues related to the elderly as part of the agency's Committee for Medicinal ... The European Medicines Agency (EMA) has established an expert

  • New EMG leadership announced

    New EMG leadership announced. The European Medicines Group has elected Matthew Speers as chair and Steve Turley as vice chair. ... Matthew Speers has been elected chair of the European Medicines Group (EMG), which represents the UK voice of

  • Ark files documentation on Cerepro

    Ark Therapeutics Group has filed documentation with the European Medicines Agency (EMA) in relation to its request for re-examination of the marketing approval application (MAA) for Cerepro, Ark's novel ... The European Committee for Medicinal Products

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Sustainable solutions Sustainable solutions

    But, with Alex elected chair of UK industry group the European Medicines Group over the summer, he's increasingly been taking a multi-company view on the issue as the Group ... Representing European pharma in the UK. Set up in 2001, the European

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Former Sanofi UK MD to head Teva UK Former Sanofi UK MD to head Teva UK

    Whilst in this position, he also served as Industry Chair of the Medicines Access Group (MAG), Chair of the European Medicines Group (EMG) and was a board member with the ABPI.

  • UCB CEO elected to the Ministerial Industry Strategy Group UCB CEO elected to the Ministerial Industry Strategy Group

    UCB's new CEO Jean-Christophe Tellier has been elected to join the Ministerial Industry Strategy Group (MISG). ... Tellier was elected by member of the European Medicines Group (EMG) and will act as group representative for the European pharma companies.

  • EMG appoints Merck and Boehringer directors as new officers EMG appoints Merck and Boehringer directors as new officers

    UK trade body the European Medicines Group (EMG) has elected David Garmon-Jones, UK managing director of Merck Sereno, as its new chair and Zinta Krumins, UK managing director of Boehringer ... Garmon-Jones (left) was previously vice chair at the

  • Lundbeck's Steve Turley re-elected as EMG chair Lundbeck's Steve Turley re-elected as EMG chair

    The European Medicines Group (EMG) has made several senior appointments, re-electing both Lundbeck's Steve Turley as chair and Actelion's Robin Bhattacherjee as vice-chair, and electing Servier's ... Turley (pictured) was originally appointed chair of

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Quick links

Infographics

Multimedia